IL6 and COVID-19: In spite of efficient B-cell depletion expected by the anti-CD20 infusion, the patient upon COVID-19 additionally presented with normal leucocyte and lymphocyte counts, elevated C-reactive protein, a slight increase in interleuchin-6 (IL-6) levels, and moderate IgG hypogammaglobulinemia.